Indian drug manufacturer recalls clobetasol propionate cream in the US over quality concerns

Major Indian drug manufacturer has voluntarily recalled 5,082 tubes of clobetasol propionate cream in the US after the product failed to meet content uniformity specifications. Manufactured at its Pithampur facility in India, the recall is classified as Class II by the US FDA, indicating potential temporary or medically reversible adverse health consequences.